President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making the comments Monday when signing an executive order intended to lower their cost.

Worried about skyrocketing prescription drug costs? Medicare's new spending cap is bringing welcome relief to seniors, with 94% of high-cost users expected to save thousands.

It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have private health insurance.

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did

The president signed an executive order that gives Health and Human Services Secretary Robert F. Kennedy Jr. 30 days to lower drug prices.

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year.

President Donald Trump on May 12, 2025, issued an executive order (EO) titled "Delivering Most-Favored-Nation Prescription Drug Pricing to

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a new evaluation tool.